PET在神经干细胞移植治疗帕金森病研究中的进展

谭海波; 刘兴党

谭海波 , 刘兴党

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 6: (253-256)

引用本文:

Citation:

PET在神经干细胞移植治疗帕金森病研究中的进展

200025 上海, 上海第二医科大学附属瑞金医院核医学科
中图分类号: R817.4

Progress of PET imaging in the study of neural stem cell transplantation treating Parkinson's disease

Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
CLC number: R817.4

摘要: PET在神经干细胞移植治疗帕金森病的研究中有重要价值,特别是治疗效果的评价、干细胞移植治疗机制的研究和不同移植部位疗效的比较方面。PET作为一种无创伤的研究手段,在神经干细胞移植治疗帕金森病的研究中的作用日益突出。
- 正电子发射体层显像 /
- 帕金森病 /
- 干细胞 /
- 移植
Abstract: PET imaging has important value in the study of neural stem cell transplantation treating Parkinson's disease, especial in the evaluation of the effect, the study of treating mechanisms and the comparation of effect in different transplantation places. PET imaging as a non-invasive method plays a more and more important role in the study of neural stem cell transplantation treating Parkinson's disease.
- positron emission tomography /
- Parkinson's disease /
- stem cell /
- transplantation
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Bjorklund A,Lindvall O.Cell replacement therapies for central nervous system disorders[J].Nature Neurosci,2000,3(6):537-544.
[2]	Lindvall O,Rehncrona S,Gustuvii B,et al.Fetal dopamine-richmesencephalic grafts in parkinson' disease[J].Lancet,1988,2(8626-8627):1483-1484.
[3]	Mckay R.Enhance proliferation,survival,and dopaminergic differentiation of CNS precursors in lowered oxygen[J].J Neurosci,2000,20(19):7377-7384.
[4]	Mckay R.Stem cell-hype and hope[J].Nature,2000,406(6794):361-364.
[5]	Studer L,Ta:ar V,Mckay RDG.Transplantation of expended mesencephalic precursors leads to recovery in parkinsonina rats[J].Nature Neurosci,1998,1(4):290-295.
[6]	Haque NS,LeBlanc CJ,Jsacson 0.Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum:y a su:set of aldehyde dehydrogenase-postive TH neurons[J].Cell Transplant,1997,6(3):239-248.
[7]	Poewe W,Scherfler C.Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice[J].Mov Disorde,2003,18(7):16-21.
[8]	Remy P,Samson Y,Hantraye P,et al.Clinical ¹⁸F-fluorodopa uptake in five grafted parkinsonian patients[J].Ann Neurol,1995,38(4):580-588.
[9]	Kuwabara H,Reith J.Human striatal L-dopa decar:oxylase activity estimate in vivo using 6-[¹⁸F] fluorodopa and positron emis-sion to-mography:error analysis and application to normal subjects[J]. J Cereb Blood Flow Metab,1993,13(1):43-56.
[10]	Snow BJ,Tooyama I,McGeer EG,et al.Human positron emission tomographic[¹⁸F] fluorodopa studies correlate with dopamine cell counts and levels[J].Ann neurol,1993,34(3):324-330.
[11]	Kordower JH,Rosenstein JM,Collier TJ,et al.Functional fetal nigral in a patient with Parkinson's disease:chemoanatomic,ultra-structural,and metabolic studies[J].J Comp Neural,1996,370(2):203-230.
[12]	Pate BD,Kawamata T,Yamada T,et al.Correlate of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices[J].Ann Neurol,1993,34(3):331-338.
[13]	Yee RE,Huang SC,Stour DB,et al.Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys:in vivo and in vitro investigation[J].J Neurochem,2000,74(3):1147-1157.
[14]	Freed CR.Transplantation of embryonic dopamine neurons for severe Parkinson's disease[J].New Engl J Med,2001,344(10):710-719.
[15]	Cochen V,Ribeiro MJ,Nguyen JP.Transplantation in parkinson's disease:PET changes correlate with the amount of grafted tissue[J].Mov Disorde,2003,18(8):928-932.
[16]	Ribeiro MJ,Vaughan RA,Loćh C,et al.Dopaminergic function and dopamine transporter density assessed with PET in parkinson's disease[J].Arch Neural,2002,59(4):580-586.
[17]	Wenning GK,Odin P,Morrish P,et al.Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease[J].Ann Neurol,1997,42(1):95-107.
[18]	Bjorklund A.Dopaminergic transplants in experimental parkinsonism:Cellular mechamisms of graft-induced functional recovery[J].Curr Opin Neurobiol,1992,2(5):683-689.
[19]	Schumacher JM,Ellias SA,Palmer EP,et al.transplantation of embryonic porcinemesencephalic tissue in patients with PD[J].Neurol,2000,54(5):1042-1050.

[1]	董爱生 , 田建明 . PET、SPECT及MRS在帕金森病诊断中的应用. 国际放射医学核医学杂志, 2005, 29(6): 244-248.
[2]	田季雨 . PET在帕金森病病理机制研究中的应用近况. 国际放射医学核医学杂志, 2003, 27(2): 53-55.
[3]	张占英 . 放射损伤病人的造血干/祖细胞移植研究进展. 国际放射医学核医学杂志, 2000, 24(5): 223-226.
[4]	李童童 , 楼菁菁 , 刘兴党 . 帕金森病心脏神经受体显像的最新研究进展. 国际放射医学核医学杂志, 2022, 46(2): 107-111. doi: 10.3760/cma.j.cn121381-202102022-00130
[5]	许靖 , 李肖红 , 秦永德 , 张奇洲 , 李毓斌 , 刘立水 , 谢彬 . 帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究. 国际放射医学核医学杂志, 2016, 40(5): 338-344. doi: 10.3760/cma.j.issn.1673-4114.2016.05.003
[6]	邓玮玮 , 张春银 . 放射性核素显像在帕金森病鉴别诊断中的应用. 国际放射医学核医学杂志, 2017, 41(2): 132-136. doi: 10.3760/cma.j.issn.1673-4114.2017.02.010
[7]	周翔 , 尹红燕 , 张一帆 . 报告基因显像监测干细胞治疗的研究进展. 国际放射医学核医学杂志, 2010, 34(5): 262-265. doi: 10.3760/cma.j.issn.1673-4114.2010.05.002
[8]	李海峰 , 张晓军 , 张锦明 . 多巴胺转运蛋白显像剂¹¹C-β-CFT在帕金森病中的应用研究. 国际放射医学核医学杂志, 2016, 40(3): 218-224. doi: 10.3760/cma.j.issn.1673-4114.2016.03.011
[9]	韩贵娟 , 谢晓菲 , 宋普姣 , 王明华 . 帕金森患者脑多巴胺转运体¹¹C-CFT PET/CT显像特点的分析. 国际放射医学核医学杂志, 2022, 46(5): 270-276. doi: 10.3760/cma.j.cn121381-202202001-00174
[10]	闫卫红 . Raclopride在帕金森病PET中的应用. 国际放射医学核医学杂志, 2005, 29(1): 27-29.